Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$77,299,697
-$25,924,361 QoQ
Shares Held
1,612,426
-42.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. NVO ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,299,697 | 1,612,426 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $103,224,058 | 2,808,818 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $179,791,445 | 3,533,637 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $300,111,054 | 5,408,381 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $229,477,551 | 3,324,798 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $381,527,172 | 5,494,343 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $480,829,684 | 5,589,743 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $644,076,769 | 5,409,228 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $704,688,674 | 4,936,869 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $721,553,424 | 5,619,575 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $490,541,689 | 4,741,824 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $187,617,583 | 2,063,092 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $150,891,094 | 932,405 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $145,971,957 | 917,255 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $135,034,126 | 997,740 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $111,531,797 | 1,119,460 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $124,631,109 | 1,118,470 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $87,197,678 | 785,211 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $46,527,040 | 415,420 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $34,997,753 | 364,522 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $32,586,192 | 388,996 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $24,735,584 | 366,888 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $24,883,780 | 356,246 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $23,722,282 | 341,672 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $22,672,250 | 346,247 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $27,962,114 | 464,487 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||